• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调节性T细胞和自然杀伤细胞介导的炎症、脑血管痉挛及动脉瘤性蛛网膜下腔出血中的迟发性脑缺血——一项系统评价和荟萃分析方法

Regulatory T Cell- and Natural Killer Cell-Mediated Inflammation, Cerebral Vasospasm, and Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage-A Systematic Review and Meta-Analysis Approach.

作者信息

Pfnür Andreas, Mayer Benjamin, Dörfer Lena, Tumani Hayrettin, Spitzer Daniel, Huber-Lang Markus, Kapapa Thomas

机构信息

Department of Neurosurgery, University Hospital Ulm, Albert-Einstein-Allee 23, 89081 Ulm, Germany.

Institute of Epidemiology and Medical Biometry, University of Ulm, Helmholtzstr. 22, 89081 Ulm, Germany.

出版信息

Int J Mol Sci. 2025 Feb 1;26(3):1276. doi: 10.3390/ijms26031276.

DOI:10.3390/ijms26031276
PMID:39941044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11818301/
Abstract

Aneurysmal subarachnoid hemorrhage (SAH) involves a significant influx of blood into the cerebrospinal fluid, representing a severe form of stroke. Despite advancements in aneurysm closure and neuro-intensive care, outcomes remain impaired due to cerebral vasospasm and delayed cerebral ischemia (DCI). Previous pharmacological therapies have not successfully reduced DCI while improving overall outcomes. As a result, significant efforts are underway to better understand the cellular and molecular mechanisms involved. This review focuses on the activation and effects of immune cells after SAH and their interactions with neurotoxic and vasoactive substances as well as inflammatory mediators. Particular attention is given to clinical studies highlighting the roles of natural killer (NK) cells and regulatory T cells (Treg) cells. Alongside microglia, astrocytes, and oligodendrocytes, NK cells and Treg cells are key contributors to the inflammatory cascade following SAH. Their involvement in modulating the neuro-inflammatory response, vasospasm, and DCI underscores their potential as therapeutic targets and prognostic markers in the post-SAH recovery process. We conducted a systematic review on T cell- and natural killer cell-mediated inflammation and their roles in cerebral vasospasm and delayed cerebral ischemia. We conducted a meta-analysis to evaluate outcomes and mortality in studies focused on NK cell- and T cell-mediated mechanisms.

摘要

动脉瘤性蛛网膜下腔出血(SAH)涉及大量血液流入脑脊液,是一种严重的中风形式。尽管在动脉瘤闭塞和神经重症监护方面取得了进展,但由于脑血管痉挛和迟发性脑缺血(DCI),预后仍然不佳。先前的药物治疗未能成功减少DCI,同时改善总体预后。因此,人们正在做出巨大努力,以更好地了解其中涉及的细胞和分子机制。本综述重点关注SAH后免疫细胞的激活和作用,以及它们与神经毒性和血管活性物质以及炎症介质的相互作用。特别关注突出自然杀伤(NK)细胞和调节性T细胞(Treg)细胞作用的临床研究。与小胶质细胞、星形胶质细胞和少突胶质细胞一样,NK细胞和Treg细胞是SAH后炎症级联反应的关键促成因素。它们参与调节神经炎症反应、血管痉挛和DCI,突出了它们作为SAH后恢复过程中治疗靶点和预后标志物的潜力。我们对T细胞和自然杀伤细胞介导的炎症及其在脑血管痉挛和迟发性脑缺血中的作用进行了系统综述。我们进行了一项荟萃分析,以评估专注于NK细胞和T细胞介导机制的研究中的预后和死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ed/11818301/1fa52e219744/ijms-26-01276-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ed/11818301/08545bc94d4b/ijms-26-01276-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ed/11818301/5d3083f1ae6b/ijms-26-01276-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ed/11818301/72e72ee473c5/ijms-26-01276-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ed/11818301/1fa52e219744/ijms-26-01276-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ed/11818301/08545bc94d4b/ijms-26-01276-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ed/11818301/5d3083f1ae6b/ijms-26-01276-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ed/11818301/72e72ee473c5/ijms-26-01276-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ed/11818301/1fa52e219744/ijms-26-01276-g004.jpg

相似文献

1
Regulatory T Cell- and Natural Killer Cell-Mediated Inflammation, Cerebral Vasospasm, and Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage-A Systematic Review and Meta-Analysis Approach.调节性T细胞和自然杀伤细胞介导的炎症、脑血管痉挛及动脉瘤性蛛网膜下腔出血中的迟发性脑缺血——一项系统评价和荟萃分析方法
Int J Mol Sci. 2025 Feb 1;26(3):1276. doi: 10.3390/ijms26031276.
2
Lipid peroxidation metabolites as biomarkers in patients with aneurysmal subarachnoid hemorrhage and cerebral vasospasm or delayed cerebral ischemia: a systematic review.脂质过氧化代谢产物作为动脉瘤性蛛网膜下腔出血和脑血管痉挛或迟发性脑缺血患者的生物标志物:一项系统评价
Neurosurg Rev. 2025 Jun 20;48(1):516. doi: 10.1007/s10143-025-03662-3.
3
Traumatic brain injury and intracranial hemorrhage-induced cerebral vasospasm: a systematic review.创伤性脑损伤和颅内出血引起的脑血管痉挛:系统评价。
Neurosurg Focus. 2017 Nov;43(5):E14. doi: 10.3171/2017.8.FOCUS17431.
4
Vasospasm on transcranial Doppler is predictive of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.经颅多普勒检测到的血管痉挛可预测动脉瘤性蛛网膜下腔出血患者的迟发性脑缺血:一项系统评价和荟萃分析。
J Neurosurg. 2016 May;124(5):1257-64. doi: 10.3171/2015.4.JNS15428. Epub 2015 Oct 23.
5
CTP for the Screening of Vasospasm and Delayed Cerebral Ischemia in Aneurysmal SAH: A Systematic Review and Meta-analysis.CTP 用于筛查动脉瘤性蛛网膜下腔出血后血管痉挛和迟发性脑缺血:系统评价和荟萃分析。
AJNR Am J Neuroradiol. 2024 Jul 8;45(7):871-878. doi: 10.3174/ajnr.A8249.
6
Role of Genetic Polymorphisms in Predicting Delayed Cerebral Ischemia and Radiographic Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.基因多态性在预测动脉瘤性蛛网膜下腔出血后迟发性脑缺血和影像学血管痉挛中的作用:一项荟萃分析。
World Neurosurg. 2015 Oct;84(4):933-41.e2. doi: 10.1016/j.wneu.2015.05.070. Epub 2015 Jun 11.
7
Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.药物治疗对颅内动脉瘤性蛛网膜下腔出血患者血管痉挛、迟发性脑缺血和临床转归的影响:系统评价和荟萃分析。
J Cereb Blood Flow Metab. 2011 Jun;31(6):1443-51. doi: 10.1038/jcbfm.2011.7. Epub 2011 Feb 2.
8
Clinical Evidence for Intravenous Milrinone to Treat Secondary Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage-A Narrative Review.静脉注射米力农治疗动脉瘤性蛛网膜下腔出血后继发性脑缺血的临床证据——叙述性综述
Acta Neurochir Suppl. 2025;136:3-9. doi: 10.1007/978-3-031-89844-0_1.
9
Thrombolysis for aneurysmal subarachnoid haemorrhage.动脉瘤性蛛网膜下腔出血的溶栓治疗
Cochrane Database Syst Rev. 2025 Jan 17;1(1):CD013748. doi: 10.1002/14651858.CD013748.pub2.
10
The effectiveness and safety of clazosentan in treating aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.克拉生坦治疗蛛网膜下腔出血的有效性和安全性:系统评价和荟萃分析。
J Clin Neurosci. 2024 Aug;126:173-181. doi: 10.1016/j.jocn.2024.06.019. Epub 2024 Jun 25.

本文引用的文献

1
Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: The Role of the Complement and Innate Immune System.动脉瘤性蛛网膜下腔出血后的迟发性脑缺血:补体和固有免疫系统的作用
Transl Stroke Res. 2025 Feb;16(1):18-24. doi: 10.1007/s12975-024-01290-5. Epub 2024 Aug 21.
2
Role of Regulatory T Cells in Intracerebral Hemorrhage.调节性T细胞在脑出血中的作用。
Mol Neurobiol. 2025 Jan;62(1):518-532. doi: 10.1007/s12035-024-04281-7. Epub 2024 Jun 14.
3
Sex-Related Differences in Mortality, Delayed Cerebral Ischemia, and Functional Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis.
动脉瘤性蛛网膜下腔出血患者死亡率、迟发性脑缺血及功能预后的性别差异:一项系统评价和荟萃分析
J Clin Med. 2024 May 9;13(10):2781. doi: 10.3390/jcm13102781.
4
Diagnosis and management of subarachnoid haemorrhage.蛛网膜下腔出血的诊断与治疗。
Nat Commun. 2024 Feb 29;15(1):1850. doi: 10.1038/s41467-024-46015-2.
5
Natural killer cells in the central nervous system.中枢神经系统中的自然杀伤细胞。
Cell Commun Signal. 2023 Nov 29;21(1):341. doi: 10.1186/s12964-023-01324-9.
6
Circulating Extracellular Vesicles in Subarachnoid Hemorrhage Patients: Characterization and Cellular Effects.蛛网膜下腔出血患者的循环细胞外囊泡:特征与细胞效应
Int J Mol Sci. 2023 Oct 5;24(19):14913. doi: 10.3390/ijms241914913.
7
To use or not to use antithrombotics in unruptured cerebrovascular malformations? A systematic review focusing on this clinical and surgical dilemma.未破裂脑血管畸形中是否使用抗血栓药物?一项聚焦于这一临床和手术困境的系统评价
Neurosurg Focus. 2023 Oct;55(4):E14. doi: 10.3171/2023.7.FOCUS23117.
8
Pathophysiology, Management, and Therapeutics in Subarachnoid Hemorrhage and Delayed Cerebral Ischemia: An Overview.蛛网膜下腔出血和迟发性脑缺血的病理生理学、管理与治疗:概述
Pathophysiology. 2023 Sep 14;30(3):420-442. doi: 10.3390/pathophysiology30030032.
9
Antiplatelet therapy in aneurysmal subarachnoid hemorrhage: an updated meta-analysis.抗血小板治疗在颅内动脉瘤性蛛网膜下腔出血中的应用:一项更新的荟萃分析。
Neurosurg Rev. 2023 Sep 4;46(1):221. doi: 10.1007/s10143-023-02120-2.
10
Regulatory T Cells Secrete IL10 to Suppress Neuroinflammation in Early Stage after Subarachnoid Hemorrhage.调节性 T 细胞分泌白细胞介素 10 以抑制蛛网膜下腔出血后早期的神经炎症。
Medicina (Kaunas). 2023 Jul 17;59(7):1317. doi: 10.3390/medicina59071317.